Kurzfassung

A Two-Year, Two-Arm, Randomized, Double-Masked, Multicenter,

Phase III Study Assessing the Efficacy and Safety of Brolucizumab

versus Aflibercept in Adult Patients with Visual Impairment due to

Diabetic Macular Edema (KITE)